Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery vs Medical Treatment in Advanced Metastatic Gastric Cancer After Conversion Therapy
NCT07757165Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Nov 2025
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in gastric cancer (GC) (2 arms), sponsored by Fudan University. Primary endpoint: Progression-Free Survival at 2 years. Started Nov 2025; status: recruiting.
02
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07757165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07757165.